title: [Ionizing radiation-regulated killing of human hepatoma cells by liposome-mediated CDglyTK gene delivery].
abstract: EGR-1 gene promoter and CDglyTK gene were used to construct the pcDNA3-EGR-CDglyTK recombinant vector, in which CDglyTK gene expression was under the control of EGR-1 gene promoter. Cationic liposome LipofectAMINE was used to transfect plasmids into human hepatoma 7402 cell line. Subsequently, the transfected cells were treated with different doses of gamma-ray. Northern blot and Western blot showed that ionizing radiation can induce CDglyTK gene expression drived by EGR-1 promoter,in a dose-dependant manner. There was no ionizing radiation-inducible effect in pcDNA3-CMV-CDglyTK control group. Ionizing radiation also markedly enhanced the sensitivity of tumor cells transfected with pcDNA3-EGR-CDglyTK to prodrugs (GCV/5-FC) in tumor cell killing. The data indicated that EGR-1 promoter was inducible by ionizing radiation, whereas the CMV promoter was not. There was a synergetic effect between GCV and 5-FC. The cytotoxic effect of the suicide gene-ionizing radiation combination was stronger than suicide gene alone or ionizing radiation alone.
authors.affiliation: Department of Biochemistry, Research Center for Human Gene Therapy, Shanghai Second Medical University, Shanghai 200025, China.
authors.forename: Xing-Jun
authors.initials: XJ
authors.lastname: Li
authors.forename: Ke-Min
authors.initials: KM
authors.lastname: Wang
authors.forename: Yue
authors.initials: Y
authors.lastname: Xu
authors.forename: Zhong-He
authors.initials: ZH
authors.lastname: Wang
authors.forename: Ai-Di
authors.initials: AD
authors.lastname: Xia
authors.forename: Shi-Shu
authors.initials: SS
authors.lastname: Chen
authors.forename: Guan-Xiang
authors.initials: GX
authors.lastname: Qian
mesh_terms: D015152:Blotting, Northern; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000235:genetics / Q000473:pathology / Q000628:therapy; D002470:Cell Survival / Q000187:drug effects / Q000528:radiation effects; D003587:Cytomegalovirus / Q000235:genetics; D043525:Cytosine Deaminase; D004268:DNA-Binding Proteins / Q000235:genetics*; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D051766:Early Growth Response Protein 1; D005437:Flucytosine / Q000494:pharmacology; D005720:Gamma Rays; D015774:Ganciclovir / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects / Q000528:radiation effects; D006801:Humans; D017874:Immediate-Early Proteins; D008081:Liposomes; D009700:Nucleoside Deaminases / Q000235:genetics / Q000378:metabolism; D010957:Plasmids / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics*; D013937:Thymidine Kinase / Q000235:genetics / Q000378:metabolism; D014157:Transcription Factors / Q000235:genetics*; D014162:Transfection; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000528:radiation effects
chemical_list: D004268:DNA-Binding Proteins; C497325:EGR1 protein, human; D051766:Early Growth Response Protein 1; D017874:Immediate-Early Proteins; D008081:Liposomes; D014157:Transcription Factors; D005437:Flucytosine; D013937:Thymidine Kinase; D009700:Nucleoside Deaminases; D043525:Cytosine Deaminase; D015774:Ganciclovir